Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

Clinical trial NCT05929768 · RECRUITING

Trial details

NCT number: NCT05929768
Sponsor: SWOG Cancer Research Network
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage IIIA Breast Cancer AJCC v8 Anatomic Stage IIIB Breast Cancer AJCC v8 Early Stage Triple-Negative Breast Carcinoma

Start date: 2023-09-15
Primary completion: 2033-03-31
Enrollment: 2400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.